Inherited erythermalgia moves a sodium channel into focus
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Voltage-gated sodium channels generate the all-or-nothing action potentials that are the defining characteristic of excitable cells. The first mutation in a human sodium channel gene, found in the skeletal muscle sodium channel gene SCN4A, and causing hyperkalemic periodic paralysis, was described in 1991.1 This mutation has turned out to be the tip of an iceberg. Of the nine genes encoding voltage-gated sodium channels, hundreds of mutations spread among six genes have now been associated with a variety of inherited, mostly episodic diseases in humans.2,3 The close conservation of sodium channels which, unlike calcium and potassium channels, are all members of a single family,4 means that very few compounds distinguish between the members of the family. Consequently, while it is clear they are differentially localized within cells and tissues, pharmacologically teasing apart the functions of different sodium channel subtypes in vitro is impossible in many cases.5 The lack of pharmacologic tools, combined with the emergence of discrete sodium channelopathies, means that the functional roles of different sodium channel subtypes …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Expedited Publication
A novel sodium channel mutation in a family with hypokalemic periodic paralysisD.E. Bulman, K.A. Scoggan, M.D. van Oene et al.Neurology, December 01, 1999 -
Articles
A novel sodium channel mutation causing a hyperkalemic paralytic and paramyotonic syndrome with variable clinical expressivityS. Wagner, H. Lerche, N. Mitrovic et al.Neurology, October 01, 1997 -
Article
Myasthenic congenital myopathy from recessive mutations at a single residue in NaV1.4Nathaniel Elia, Johanna Palmio, Marisol Sampedro Castañeda et al.Neurology, March 01, 2019 -
Articles
Correlating phenotype and genotype in the periodic paralysesT. M. Miller, M. R. Dias da Silva, H. A. Miller et al.Neurology, November 08, 2004